EXCLUSIVE: The Maze Runner filmmakers and their OddBall Entertainment studio have signed with CAA, we can tell you. Wes Ball ...

The Orioles announced this evening that they’ve agreed to a deal with utilityman Jorge Mateo to avoid arbitration. It’s a one-year contract that comes with a club option for 2026. Mateo has ...

Jorge Polanco is staying in Seattle. The veteran infielder signed a one-year deal with a vesting option for 2026 with the Mariners on Thursday, according to The Post’s Jon Heyman. The deal will ...

Advertisement No such resolution is near, and the Astros continue to show strong interest in another option, veteran infielder Jorge Polanco, two league sources told The Athletic on Monday.

After making history as the first 'MotoGP' champion from an Independent team, Jorge Martin switches from Pramac Ducati to the official Aprilia team for 2025. Jorge Martin won the Red Bull Rookies ...

Utilizing the latest The Maze Runner codes can help you complete mazes and survive in Roblox. Survival horror game The Maze Runner revolves around puzzles. In it, you control a character who must ...

As they sort through options following the departure of Gleyber Torres, the Yankees have checked in on 11-year pro Jorge Polanco, a source said. The club could use a second baseman or third ...

And so Saturday, the Nationals attempted to address their need for relief experience and add their most likely option to close in one fell swoop, agreeing with right-hander Jorge López on a one ...

To save their friends, they must break into the legendary Last City, a WCKD-controlled labyrinth that may turn out to be the deadliest maze of all. Anyone who makes it out alive will get answers ...

Jorge Martin made history in 2024 by clinching the MotoGP™ World Championship, becoming the first Independent World Champion of the modern era and denying Ducati’s Pecco Bagnaia a third title.

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...